ID PURL_BACSU Reviewed; 742 AA. AC P12042; DT 01-OCT-1989, integrated into UniProtKB/Swiss-Prot. DT 07-JUL-2009, sequence version 2. DT 02-SEP-2026, entry version 171. DE RecName: Full=Phosphoribosylformylglycinamidine synthase subunit PurL {ECO:0000255|HAMAP-Rule:MF_00420}; DE Short=FGAM synthase {ECO:0000255|HAMAP-Rule:MF_00420}; DE EC=6.3.5.3 {ECO:0000255|HAMAP-Rule:MF_00420}; DE AltName: Full=Formylglycinamide ribonucleotide amidotransferase subunit II {ECO:0000255|HAMAP-Rule:MF_00420}; DE Short=FGAR amidotransferase II {ECO:0000255|HAMAP-Rule:MF_00420}; DE Short=FGAR-AT II {ECO:0000255|HAMAP-Rule:MF_00420}; DE AltName: Full=Glutamine amidotransferase PurL {ECO:0000255|HAMAP-Rule:MF_00420}; DE AltName: Full=Phosphoribosylformylglycinamidine synthase subunit II {ECO:0000255|HAMAP-Rule:MF_00420}; GN Name=purL {ECO:0000255|HAMAP-Rule:MF_00420}; GN OrderedLocusNames=BSU06480; OS Bacillus subtilis (strain 168). OC Bacteria; Bacillati; Bacillota; Bacilli; Caryophanales; Bacillaceae; OC Bacillus. OX NCBI_TaxID=224308; RN [1] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RX PubMed=3036807; DOI=10.1016/s0021-9258(18)47560-6; RA Ebbole D.J., Zalkin H.; RT "Cloning and characterization of a 12-gene cluster from Bacillus subtilis RT encoding nine enzymes for de novo purine nucleotide synthesis."; RL J. Biol. Chem. 262:8274-8287(1987). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RC STRAIN=168; RX PubMed=9384377; DOI=10.1038/36786; RA Kunst F., Ogasawara N., Moszer I., Albertini A.M., Alloni G., Azevedo V., RA Bertero M.G., Bessieres P., Bolotin A., Borchert S., Borriss R., RA Boursier L., Brans A., Braun M., Brignell S.C., Bron S., Brouillet S., RA Bruschi C.V., Caldwell B., Capuano V., Carter N.M., Choi S.-K., RA Codani J.-J., Connerton I.F., Cummings N.J., Daniel R.A., Denizot F., RA Devine K.M., Duesterhoeft A., Ehrlich S.D., Emmerson P.T., Entian K.-D., RA Errington J., Fabret C., Ferrari E., Foulger D., Fritz C., Fujita M., RA Fujita Y., Fuma S., Galizzi A., Galleron N., Ghim S.-Y., Glaser P., RA Goffeau A., Golightly E.J., Grandi G., Guiseppi G., Guy B.J., Haga K., RA Haiech J., Harwood C.R., Henaut A., Hilbert H., Holsappel S., Hosono S., RA Hullo M.-F., Itaya M., Jones L.-M., Joris B., Karamata D., Kasahara Y., RA Klaerr-Blanchard M., Klein C., Kobayashi Y., Koetter P., Koningstein G., RA Krogh S., Kumano M., Kurita K., Lapidus A., Lardinois S., Lauber J., RA Lazarevic V., Lee S.-M., Levine A., Liu H., Masuda S., Mauel C., RA Medigue C., Medina N., Mellado R.P., Mizuno M., Moestl D., Nakai S., RA Noback M., Noone D., O'Reilly M., Ogawa K., Ogiwara A., Oudega B., RA Park S.-H., Parro V., Pohl T.M., Portetelle D., Porwollik S., RA Prescott A.M., Presecan E., Pujic P., Purnelle B., Rapoport G., Rey M., RA Reynolds S., Rieger M., Rivolta C., Rocha E., Roche B., Rose M., Sadaie Y., RA Sato T., Scanlan E., Schleich S., Schroeter R., Scoffone F., Sekiguchi J., RA Sekowska A., Seror S.J., Serror P., Shin B.-S., Soldo B., Sorokin A., RA Tacconi E., Takagi T., Takahashi H., Takemaru K., Takeuchi M., RA Tamakoshi A., Tanaka T., Terpstra P., Tognoni A., Tosato V., Uchiyama S., RA Vandenbol M., Vannier F., Vassarotti A., Viari A., Wambutt R., Wedler E., RA Wedler H., Weitzenegger T., Winters P., Wipat A., Yamamoto H., Yamane K., RA Yasumoto K., Yata K., Yoshida K., Yoshikawa H.-F., Zumstein E., RA Yoshikawa H., Danchin A.; RT "The complete genome sequence of the Gram-positive bacterium Bacillus RT subtilis."; RL Nature 390:249-256(1997). RN [3] RP PROTEIN SEQUENCE OF N-TERMINUS, FUNCTION, CATALYTIC ACTIVITY, MASS RP SPECTROMETRY, BIOPHYSICOCHEMICAL PROPERTIES, AND SUBUNIT. RX PubMed=15301530; DOI=10.1021/bi049127h; RA Hoskins A.A., Anand R., Ealick S.E., Stubbe J.; RT "The formylglycinamide ribonucleotide amidotransferase complex from RT Bacillus subtilis: metabolite-mediated complex formation."; RL Biochemistry 43:10314-10327(2004). RN [4] RP SEQUENCE REVISION TO 513. RX PubMed=19383706; DOI=10.1099/mic.0.027839-0; RA Barbe V., Cruveiller S., Kunst F., Lenoble P., Meurice G., Sekowska A., RA Vallenet D., Wang T., Moszer I., Medigue C., Danchin A.; RT "From a consortium sequence to a unified sequence: the Bacillus subtilis RT 168 reference genome a decade later."; RL Microbiology 155:1758-1775(2009). CC -!- FUNCTION: Part of the phosphoribosylformylglycinamidine synthase CC complex involved in the purines biosynthetic pathway. Catalyzes the CC ATP-dependent conversion of formylglycinamide ribonucleotide (FGAR) and CC glutamine to yield formylglycinamidine ribonucleotide (FGAM) and CC glutamate. The FGAM synthase complex is composed of three subunits. CC PurQ produces an ammonia molecule by converting glutamine to glutamate. CC PurL transfers the ammonia molecule to FGAR to form FGAM in an ATP- CC dependent manner. PurS interacts with PurQ and PurL and is thought to CC assist in the transfer of the ammonia molecule from PurQ to PurL. CC {ECO:0000255|HAMAP-Rule:MF_00420, ECO:0000269|PubMed:15301530}. CC -!- CATALYTIC ACTIVITY: CC Reaction=N(2)-formyl-N(1)-(5-phospho-beta-D-ribosyl)glycinamide + L- CC glutamine + ATP + H2O = 2-formamido-N(1)-(5-O-phospho-beta-D- CC ribosyl)acetamidine + L-glutamate + ADP + phosphate + H(+); CC Xref=Rhea:RHEA:17129, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, CC ChEBI:CHEBI:29985, ChEBI:CHEBI:30616, ChEBI:CHEBI:43474, CC ChEBI:CHEBI:58359, ChEBI:CHEBI:147286, ChEBI:CHEBI:147287, CC ChEBI:CHEBI:456216; EC=6.3.5.3; Evidence={ECO:0000255|HAMAP- CC Rule:MF_00420, ECO:0000269|PubMed:15301530}; CC -!- CATALYTIC ACTIVITY: CC Reaction=L-glutamine + H2O = L-glutamate + NH4(+); CC Xref=Rhea:RHEA:15889, ChEBI:CHEBI:15377, ChEBI:CHEBI:28938, CC ChEBI:CHEBI:29985, ChEBI:CHEBI:58359; CC Evidence={ECO:0000269|PubMed:15301530}; CC -!- BIOPHYSICOCHEMICAL PROPERTIES: CC Kinetic parameters: CC KM=181 uM for ATP (FGAM synthase activity at pH 7.2 and 37 degrees CC Celsius) {ECO:0000269|PubMed:15301530}; CC KM=398 uM for ATP (Glutamine amidotransferase activity at pH 7.2 and CC 37 degrees Celsius) {ECO:0000269|PubMed:15301530}; CC KM=507 uM for FGAR (FGAM synthase activity at pH 7.2 and 37 degrees CC Celsius) {ECO:0000269|PubMed:15301530}; CC KM=1.3 mM for glutamine (FGAM synthase activity at pH 7.2 and 37 CC degrees Celsius) {ECO:0000269|PubMed:15301530}; CC KM=2.5 mM for FGAR (Glutamine amidotransferase activity at pH 7.2 and CC 37 degrees Celsius) {ECO:0000269|PubMed:15301530}; CC KM=3.5 mM for NH3 (Glutamine amidotransferase activity at pH 7.2 and CC 37 degrees Celsius) {ECO:0000269|PubMed:15301530}; CC Note=kcat is 2.49 sec(-1) for FGAM synthase activity with FGAR as CC substrate (at pH 7.2 and 37 degrees Celsius). kcat is 0.044 sec(-1) CC for glutamine amidotransferase activity with NH3 as substrate (at pH CC 7.2 and 37 degrees Celsius).; CC -!- PATHWAY: Purine metabolism; IMP biosynthesis via de novo pathway; 5- CC amino-1-(5-phospho-D-ribosyl)imidazole from N(2)-formyl-N(1)-(5- CC phospho-D-ribosyl)glycinamide: step 1/2. {ECO:0000255|HAMAP- CC Rule:MF_00420}. CC -!- SUBUNIT: Monomer. Part of the FGAM synthase complex composed of 1 PurL, CC 1 PurQ and 2 PurS subunits. {ECO:0000255|HAMAP-Rule:MF_00420, CC ECO:0000269|PubMed:15301530}. CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000255|HAMAP-Rule:MF_00420}. CC -!- SIMILARITY: Belongs to the FGAMS family. {ECO:0000255|HAMAP- CC Rule:MF_00420}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; J02732; AAA22679.1; -; Genomic_DNA. DR EMBL; AL009126; CAB12468.2; -; Genomic_DNA. DR PIR; G29326; SYBS2G. DR RefSeq; NP_388530.2; NC_000964.3. DR RefSeq; WP_003244429.1; NC_000964.3. DR AlphaFoldDB; P12042; -. DR SMR; P12042; -. DR FunCoup; P12042; 610. DR IntAct; P12042; 1. DR MINT; P12042; -. DR STRING; 224308.BSU06480; -. DR PaxDb; 224308-BSU06480; -. DR EnsemblBacteria; CAB12468; CAB12468; BSU_06480. DR GeneID; 939233; -. DR KEGG; bsu:BSU06480; -. DR PATRIC; fig|224308.179.peg.704; -. DR eggNOG; COG0046; Bacteria. DR InParanoid; P12042; -. DR OrthoDB; 9804441at2; -. DR PhylomeDB; P12042; -. DR BioCyc; BSUB:BSU06480-MONOMER; -. DR BioCyc; MetaCyc:BSU06480-MONOMER; -. DR UniPathway; UPA00074; UER00128. DR Proteomes; UP000001570; Chromosome. DR AbasyAtlas; P12042; -. DR GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell. DR GO; GO:0005524; F:ATP binding; IDA:UniProtKB. DR GO; GO:0004359; F:glutaminase activity; IEA:RHEA. DR GO; GO:0000287; F:magnesium ion binding; IEA:UniProtKB-UniRule. DR GO; GO:0004642; F:phosphoribosylformylglycinamidine synthase activity; IDA:UniProtKB. DR GO; GO:0006189; P:'de novo' IMP biosynthetic process; IEA:UniProtKB-UniRule. DR GO; GO:0006164; P:purine nucleotide biosynthetic process; IDA:UniProtKB. DR CDD; cd02203; PurL_repeat1; 1. DR CDD; cd02204; PurL_repeat2; 1. DR FunFam; 3.30.1330.10:FF:000004; Phosphoribosylformylglycinamidine synthase subunit PurL; 1. DR FunFam; 3.30.1330.10:FF:000011; Phosphoribosylformylglycinamidine synthase subunit PurL; 1. DR FunFam; 3.90.650.10:FF:000009; Phosphoribosylformylglycinamidine synthase subunit PurL; 1. DR FunFam; 3.90.650.10:FF:000013; Phosphoribosylformylglycinamidine synthase subunit PurL; 1. DR Gene3D; 3.90.650.10; PurM-like C-terminal domain; 2. DR Gene3D; 3.30.1330.10; PurM-like, N-terminal domain; 2. DR HAMAP; MF_00420; PurL_2; 1. DR InterPro; IPR010074; PRibForGlyAmidine_synth_PurL. DR InterPro; IPR041609; PurL_linker. DR InterPro; IPR010918; PurM-like_C_dom. DR InterPro; IPR036676; PurM-like_C_sf. DR InterPro; IPR016188; PurM-like_N. DR InterPro; IPR036921; PurM-like_N_sf. DR NCBIfam; TIGR01736; FGAM_synth_II; 1. DR NCBIfam; NF002290; PRK01213.1; 1. DR PANTHER; PTHR43555; PHOSPHORIBOSYLFORMYLGLYCINAMIDINE SYNTHASE SUBUNIT PURL; 1. DR PANTHER; PTHR43555:SF1; PHOSPHORIBOSYLFORMYLGLYCINAMIDINE SYNTHASE SUBUNIT PURL; 1. DR Pfam; PF00586; AIRS; 2. DR Pfam; PF02769; AIRS_C; 2. DR Pfam; PF18072; FGAR-AT_linker; 1. DR PIRSF; PIRSF001587; FGAM_synthase_II; 1. DR SUPFAM; SSF56042; PurM C-terminal domain-like; 2. DR SUPFAM; SSF55326; PurM N-terminal domain-like; 2. PE 1: Evidence at protein level; KW ATP-binding; Cytoplasm; Direct protein sequencing; Ligase; Magnesium; KW Metal-binding; Nucleotide-binding; Purine biosynthesis; Reference proteome. FT INIT_MET 1 FT /note="Removed" FT CHAIN 2..742 FT /note="Phosphoribosylformylglycinamidine synthase subunit FT PurL" FT /id="PRO_0000100440" FT ACT_SITE 54 FT /evidence="ECO:0000255|HAMAP-Rule:MF_00420" FT ACT_SITE 100 FT /note="Proton acceptor" FT /evidence="ECO:0000255|HAMAP-Rule:MF_00420" FT BINDING 57 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000255|HAMAP-Rule:MF_00420" FT BINDING 96 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000255|HAMAP-Rule:MF_00420" FT BINDING 98 FT /ligand="Mg(2+)" FT /ligand_id="ChEBI:CHEBI:18420" FT /ligand_label="1" FT /evidence="ECO:0000255|HAMAP-Rule:MF_00420" FT BINDING 99..102 FT /ligand="substrate" FT /evidence="ECO:0000255|HAMAP-Rule:MF_00420" FT BINDING 121 FT /ligand="substrate" FT /evidence="ECO:0000255|HAMAP-Rule:MF_00420" FT BINDING 122 FT /ligand="Mg(2+)" FT /ligand_id="ChEBI:CHEBI:18420" FT /ligand_label="2" FT /evidence="ECO:0000255|HAMAP-Rule:MF_00420" FT BINDING 225 FT /ligand="substrate" FT /evidence="ECO:0000255|HAMAP-Rule:MF_00420" FT BINDING 245 FT /ligand="substrate" FT /evidence="ECO:0000255|HAMAP-Rule:MF_00420" FT BINDING 273 FT /ligand="Mg(2+)" FT /ligand_id="ChEBI:CHEBI:18420" FT /ligand_label="2" FT /evidence="ECO:0000255|HAMAP-Rule:MF_00420" FT BINDING 317..319 FT /ligand="substrate" FT /evidence="ECO:0000255|HAMAP-Rule:MF_00420" FT BINDING 537 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000255|HAMAP-Rule:MF_00420" FT BINDING 538 FT /ligand="Mg(2+)" FT /ligand_id="ChEBI:CHEBI:18420" FT /ligand_label="1" FT /evidence="ECO:0000255|HAMAP-Rule:MF_00420" FT BINDING 540 FT /ligand="substrate" FT /evidence="ECO:0000255|HAMAP-Rule:MF_00420" FT CONFLICT 513 FT /note="F -> L (in Ref. 1; AAA22679)" FT /evidence="ECO:0000305" SQ SEQUENCE 742 AA; 80325 MW; 58F527FD16271557 CRC64; MSLLLEPSKE QIKEEKLYQQ MGVSDDEFAL IESILGRLPN YTEIGIFSVM WSEHCSYKNS KPILRKFPTS GERVLQGPGE GAGIVDIGDN QAVVFKIESH NHPSALEPYQ GAATGVGGII RDVFSMGARP IAVLNSLRFG ELTSPRVKYL FEEVVAGIAG YGNCIGIPTV GGEVQFDSSY EGNPLVNAMC VGLINHEDIK KGQAKGVGNT VMYVGAKTGR DGIHGATFAS EEMSDSSEEK RSAVQVGDPF MEKLLLEACL EVIQCDALVG IQDMGAAGLT SSSAEMASKA GSGIEMNLDL IPQRETGMTA YEMMLSESQE RMLLVIERGR EQEIIDIFDK YDLEAVSVGH VTDDKMLRLT HKGEVVCELP VDALAEEAPV YHKPSQEPAY YREFLETDVP APQIEDANEM LKALLQQPTI ASKEWVYDQY DYMVRTNTVV APGSDAGVLR IRGTKKALAM TTDCNARYLY LDPEVGGKIA VAEAARNIIC SGAEPLAVTD NLNFGNPEKP EIFWQIEKAA DGISEACNVL STPVIGGNVS LYNESNGTAI YPTPVIGMVG LIEDTAHITT QHFKQAGDLV YVIGETKPEF AGSELQKMTE GRIYGKAPQI DLDVELSRQK ALLDAIKKGF VQSAHDVSEG GLGVAIAESV MTTENLGANV TVEGEAALLF SESQSRFVVS VKKEHQAAFE ATVKDAVHIG EVTADGILAI QNQDGQQMIH AQTKELERVW KGAIPCLLKS KA //